Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVT 302 for Craving and Withdrawal in Smokers
NCT00622752Phase 2Completed
- Sponsor
- Evotec SE
- Start
- Feb 2008
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sembragiline in nicotine dependence, sponsored by Evotec SE. Started Feb 2008; status: completed.
02
Drugs
sembragiline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00622752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622752.